160
Participants
Start Date
April 19, 2022
Primary Completion Date
July 16, 2025
Study Completion Date
December 31, 2025
Sotorasib
Sotorasib will be administered orally
Panitumumab
Panitumumab will be administered as intravenous (IV) infusion
Trifluridine and Tipiracil
Trifluridine and Tipiracil will be administered orally
Regorafenib
Regorafenib will be administered orally
Chris OBrien Lifehouse, Camperdown
GenesisCare -North Shore (Oncology), St Leonards
Westmead Hospital, Westmead
The Queen Elizabeth Hospital, Woodville South
National Taiwan University Hospital, Taipei
White Plains Hospital Center for Cancer Care, White Plains
Taipei Veterans General Hospital, Taipei
General Hospital of Athens Laiko, Athens
Evgenidio Hospital I Agia Trias, Athens
Azienda Ospedaliera Santa Croce e Carle, Confreria (CN)
Upstate University Hospital, Syracuse
Charite Universitaetsmedizin Berlin, Charité Campus Virchow-Klinikum, Berlin
Hospital Universitario Reina Sofia, Córdoba
Hygeia Hospital, Athens
Ospedale Policlinico San Martino IRCCS, Genova
Lancaster General Hospital Ann B Barshinger Cancer Institute, Lancaster
Hospital Universitario Virgen de las Nieves, Granada
Azienda Sanitaria Locale 5 Spezzino Ospedale S Andrea, La Spezia
Johns Hopkins University School of Medicine, Washington D.C.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Istituto Ospedaliero Fondazione Poliambulanza, Brescia
University Hospital of Patras, Pátrai
Moses H Cone Memorial Hospital, Greensboro
Hospital Universitario La Paz, Madrid
Azienda Ospedaliero Universitaria Maggiore della Carita, Novara
Northwest Georgia Oncology Centers PC, Marietta
Hospital Universitario de Navarra, Pamplona
Complexo Hospitalario Universitario de Ourense, Ourense
Cancer Specialists of North Florida, Jacksonville
Lakes Research LLC, Miami Lakes
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan District
Hôpital Haut -lévêque, Pessac
Institut regional du Cancer Montpellier, Montpellier
Istituto Oncologico Veneto IRCCS, Padua
Central Alabama Research, Birmingham
Azienda Unita Locale Socio Sanitaria Berica 8, Vicenza
Universitaetsmedizin Goettingen - Georg-August-Universitaet, Göttingen
Sarah Cannon Research Institute, Nashville
Hospital Universitario Marques de Valdecilla, Santander
Azienda Unita Sanitaria Locale di Reggio Emilia Arcispedale Santa Maria Nuova, Reggio Emilia
The Mark H Zangmeister Center, Columbus
Hospital General Universitario de Valencia, Valencia
Revive Research Institute, Sterling Heights
Revive Research Institute, Farmington Hills
Sparrow Clinical Research Institute, Lansing
Azienda Ospedaliera Universitaria Careggi, Florence
Theagenion Anticancer Hospital, Thessaloniki
Agios Loukas Clinic, Thessaloniki
Azienda Ospedaliera Universitaria Pisana Ospedale Santa Chiara, Pisa
Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, Lyon Cédex 3
National Cheng Kung University Hospital, Tainan City
University Hospital of Heraklion, Heraklion - Crete
Universitaetsklinikum der Eberhard Karls Universitaet Tuebingen, Tübingen
Azienda Ospedaliera Cardinale Giovanni Panico, Tricase
Azienda Unita Sanitaria Locale LE Presidio Ospedaliero Vito Fazzi Polo Oncologico Giovanni Paolo II, Lecce
Hôpital Européen Georges Pompidou, Paris
Kelsey Research Foundation, Houston
Best Cancer Care & Hematology, Houston
Lumi Research, Kingwood
Azienda Ospedaliero Universitaria Luigi Vanvitelli, Napoli
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Giovanni Pascale, Napoli
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Klinikum der Universitaet Muenchen Campus Grosshadern, München
Azienda Ospedaliera San Carlo, Potenza
City of Hope National Medical Center, Duarte
University of California Irvine, Orange
Azienda Ospedaliera Rilievo Nazionale e Alta Specializzazione Garibaldi Nesima, Catania
University of Michigan, Ann Arbor
Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet Dresden, Dresden
Azienda Ospedaliero Universitaria di Cagliari Policlinico Duilio Casula, Monserrato CA
Policlinico Universitario Agostino Gemelli, Roma
Azienda Ospedaliera San Giovanni Addolorata, Roma
Fondazione Policlinico Tor Vergata, Roma (RM)
Aichi Medical University Hospital, Nagakute-shi
Chiba Cancer Center, Chiba
National Cancer Center Hospital East, Kashiwa-shi
National Hospital Organization Shikoku Cancer Center, Matsuyama
National Hospital Organization Kyushu Cancer Center, Fukuoka
Hokkaido University Hospital, Sapporo
Hyogo Cancer Center, Akashi-shi
St Marianna University Hospital, Kawasaki-shi
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center, Yokohama
National Hospital Organization Osaka National Hospital, Osaka
Osaka University Hospital, Suita-shi
Saitama Cancer Center, Kitaadachi-gun
Shizuoka Cancer Center, Sunto-gun
National Cancer Center Hospital, Chuo-ku
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
Health Pharma Professional Research SA de CV, Mexico City
Superare Centro de Infusion SA de CV, Mexico City
Trials In Medicine SC, Mexico City
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Vall d Hebron, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital General Universitario de Elche, Elche
Beatson West of Scotland Cancer Centre, Glasgow
Royal Free Hospital, London
Royal Marsden Hospital, London
Maidstone Hospital, Maidstone
Mount Vernon Cancer Centre, Northwood
Royal Marsden Hospital, Sutton
Lead Sponsor
Amgen
INDUSTRY